Is There a Relationship Between the Risk of Injury and Posture in Wrestlers?

January 11, 2021 updated by: Ankara Yildirim Beyazıt University
This study was planned to investigate the relationship between the risk of injury and posture in wrestlers. The study will be included male wrestlers. The spine posture and flexibility of the athletes will be measured during standing position with the Idiag M360® brand Spinal Mouse (SM), while the overall body posture will be measured from the anterior and lateral sides using the New York Posture Analysis Method (NYPAM). Injury risks of the athletes will be evaluated by Functional Movement Screen (FMS) which was consisting of seven basic movement patterns.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

68

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Etlik
      • Ankara, Etlik, Turkey, 06010
        • Ankara Yıldırım Beyazıt University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

In this cross-sectional study, 18- to 40-year-old elite wrestler who have won medals in their championships from four different clubs will be tested

Description

Inclusion Criteria:

  • Being between the ages of 18 and 40
  • To be a professional wrestler who won medals in the Turkey championships

Exclusion Criteria:

  • had injury for in the last 6 months
  • had a history of surgery, or chronic and progressive disease
  • had any orthopaedic or neurological problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Posture Assessment
Posture will be assessed with New York Posture Rating Chart (NYPR) originally published in 1958
Sagittal spinal alignment and mobility
Sagittal spinal alignment and mobility will be measured using the Spinal Mouse (IdiagAG Mülistrasse 18 CH-8320 Fehraltorf, Switzerland), a computer-aided, non-invasive device.
Injury risk assessment
Injury risk will be evaluated with Functional Movement Screen (FMS) test battery. A previous systematic review has demonstrated acceptable reliability for the FMS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Posture Assessment
Time Frame: 2 weeks
Posture will be assessed with New York Posture Rating Chart (NYPR) originally published in 1958
2 weeks
Sagittal spinal alignment and mobility
Time Frame: 2 weeks
Sagittal spinal alignment and mobility will be measured using the Spinal Mouse (IdiagAG Mülistrasse 18 CH-8320 Fehraltorf, Switzerland), a computer-aided, non-invasive device
2 weeks
Injury risk assessment
Time Frame: 2 weeks
Injury risk will be evaluated with Functional Movement Screen (FMS) test battery. A previous systematic review has demonstrated acceptable reliability for the FMS
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2020

Primary Completion (Actual)

October 30, 2020

Study Completion (Actual)

November 12, 2020

Study Registration Dates

First Submitted

October 10, 2020

First Submitted That Met QC Criteria

October 10, 2020

First Posted (Actual)

October 19, 2020

Study Record Updates

Last Update Posted (Actual)

January 12, 2021

Last Update Submitted That Met QC Criteria

January 11, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2018-38/364

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Risk Reduction

3
Subscribe